Marker and probe composition for screening gastric cancer and application of marker and probe composition
A marker and composition technology, applied in the biological field, can solve problems such as the lack of non-invasive diagnostic methods, achieve high sensitivity and accuracy, and reduce harm
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0370] The preparation of the chip is mainly based on a glass sheet or a silicon sheet as a carrier, and oligonucleotide fragments or cDNAs are arranged on the carrier in sequence as probes by means of in situ synthesis and micro-array.
[0371] The chip of the present invention is based on the signal detection of DNA sequence hybridization after bisulfite treatment. Bisulfite treatment is to change unmethylated cytosine into uracil, while methylated cytosine remains unchanged. Change, then convert uracil to thymine, and finally carry out chip hybridization; finally judge the type of base added according to the fluorescent color, and then determine whether the site is methylated.
[0372] The present invention provides a method for gastric cancer screening, which comprises:
[0373] detect the methylation level of the marker, and
[0374] The risk of the subject suffering from gastric cancer is judged based on the methylation level, and the marker is selected from one of the ...
Embodiment 1
[0378] Example 1 Screening markers
[0379] 1) Sample collection: Download the 450k methylation microarray cancer tissue data in TCGA, involving a total of 7,769 cancer tissue samples of 26 types of tumors, including adrenocortical carcinoma (80), bladder urothelial carcinoma (409), acute myeloid Leukemia (140), brain low-grade glioma (654), breast cancer (740), cervical cancer (286), colorectal cancer (348), esophageal cancer (183), uveal melanoma (80), head and neck squamous Stem cell carcinoma (527), kidney cancer (660), liver cancer (377), lung adenocarcinoma (425), lung squamous cell carcinoma (372), diffuse large B-cell lymphoma (29), ovarian serous cystadenocarcinoma ( 10), pancreatic cancer (184), mesothelioma (116), prostate cancer (488), skin melanoma (104), sarcoma (117), gastric cancer (397), testicular cancer (134), thymus cancer (94) , thyroid cancer (506), endometrial cancer (309). For healthy people, Boercheng collected the plasma of 38 healthy people, and th...
Embodiment 2
[0551] 6 cases of human samples (S1-3 are samples from healthy people, S4-6 are samples from patients with gastric cancer), using the methylation marker detection method of the application, collecting peripheral blood according to the method in Example 1; building a library, and passing Illumina Platform sequencing; the sequencing data is analyzed through the above-mentioned bioinformatics process to obtain the methylation level of each marker. According to the threshold of each marker, the patient’s disease condition is predicted. If it exceeds the threshold, it is a cancer sample; if it is low The threshold is a healthy sample, and the specific results are shown in Table 19:
[0552] Among the interpretation results, 0 represents the classification as normal, that is, healthy; 1 represents the classification as abnormal, that is, tumor.
[0553] Table 19 Methylation values and interpretation results of samples
[0554]
[0555]
[0556] To sum up, the inventors of t...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com